Does a single Pseudomonas aeruginosa isolation predict COPD mortality?

European Respiratory Journal

Volumn 44, Issue 3, 2014, Pages 794-797

  Boutou, Afroditi K ^a   Raste, Yogini ^a   Reid, Jeremy ^a   Alshafi, Khalid ^b   Polkey, Michael I ^a   Hopkinson, Nicholas S ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; BACTERIUM ISOLATION; BODY MASS; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DETERIORATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LETTER; LONG TERM SURVIVAL; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESIDUAL VOLUME; SPUTUM ANALYSIS; SPUTUM CULTURE; SURVIVAL PREDICTION; TOTAL LUNG CAPACITY; COMPLICATION; HOSPITALIZATION; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; MICROBIOLOGY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; SPUTUM; TREATMENT OUTCOME;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM; TREATMENT OUTCOME;

EID: 84907338080     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00023414     Document Type: Letter

References (10)

1. Kelly JL, Bamsey O, Smith C, et al. Health status assessment in routine clinical practice: the chronic obstructive pulmonary disease assessment test score in outpatients. Respiration 2012; 84: 193-199.
2. Wilson R, Sethi S, Anzueto A, et al. Antibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary disease. J Infect 2013; 67: 497-515.
3. Pressler T, Bohmova C, Conway S, et al. Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report. J Cyst Fibros 2011; 10: Suppl. 2, S75-S78.
4. Loebinger MR, Wells AU, Hansell DM, et al. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J 2009; 34: 843-849.
5. Almagro P, Salvadó M, Garcia-Vidal C, et al. Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease. Respiration 2012; 84: 36-43.
6. Lin SH, Kuo PH, Hsueh PR, et al. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa. Respirology 2007; 12: 81-87.
7. Montero M, Domínguez M, Orozco-Levi M, et al. Mortality of COPD patients infected with multi-resistant Pseudomonas aeruginosa: a case and control study. Infection 2009; 37: 16-19.
8. Murphy TF. The many faces of Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Clin Infect Dis 2008; 1534-1535.
9. Renom F, Yáñez A, Garau M, et al. Prognosis of COPD patients requiring frequent hospitalization: role of airway infection. Respir Med 2010; 104: 840-848.
10. Boutou AK, Shrikrishna D, Tanner RJ, et al. Lung function indices for predicting mortality in COPD. Eur Respir J 2013; 42: 616-625.